MSci Cancer Biomedicine
About this course
MSci in Cancer Biomedicine, a medicine degree centred on the study of oncology, cellular biology, and clinical treatment methods. Core topics include Statistics and Research Methods. The curriculum spans four academic years and culminates in an extended research project. The first year covers human physiology and cellular processes through compulsory modules such as Foundations in Human Physiology and Cellular Biology, Cardiovascular and Respiratory Function in Health and Disease, and Infection, Inflammation and Repair. The second year examines cancer mechanisms and diagnostics through compulsory study in Cancer Biology and Therapeutics, Clinical Cancer: from epidemiology to diagnosis to treatment, and Pathogens and Cancer, alongside optional choices like Immunology and Pharmacology and Drug Action. The third year focuses on advanced clinical applications and specialized treatments via compulsory modules including Precision Cancer Medicine, Paediatric and Young Adult Cancer: Basic Research and Clinical Applications, and a Structured Cancer Biomedicine Research Project, with optional topics such as Stem Cell Therapies and Nanotechnology in Medicine. The fourth and final year deepens methodological expertise and research capabilities through compulsory study of Advanced Therapies in Cancer Care and an Extended Cancer Biomedicine Research Project.
Written by AI from the university's course page and module list. It can get details wrong, so check the official course page before you rely on it.
Entry requirements
A level: AAA (Biology and Chemistry required.) IB: 38 points (A total of 18 points in three higher level subjects including 6 in Biology and Chemistry, with no higher level score below 5.)
See the highest paying Medicine & Dentistry degrees in the UK →
What students say
Based on about 10 final-year students who answered (a small group: a rough guide only)
- Teaching on my course: 92%
- Learning opportunities: 98%
- Assessment and feedback: 82%
- Academic support: 88%
- Organisation and management: 77%
- Learning resources: 82%
- Student voice: 92%
Do students stay on the course?
Based on about 195 students who started, across similar courses at this university
- Continued on course: 82%
- Gained a higher qualification: 10%
- Left higher education: 6%
- Moved to a lower qualification: 2%
What graduates do next
Based on about 10 graduates who answered, across similar courses at this university (a small group: a rough guide only)
- Working: 45%
- Working and studying: 35%
- Further study: 20%
Most common jobs
- Administrative occupations: 25%
- Information Technology Professionals: 10%
- Business, Research and Administrative Professionals: 10%
- Animal care and control services: 10%
- Business and Financial Project Management Professionals: 10%
- Find their work meaningful: 80%
- Feel on track for their future plans: 65%
- Use what they learnt on the course: 40%
Where graduates work (5 years on)
Based on about 565 graduates, across similar courses at this university
- North East: 2%
- North West: 6%
- Yorkshire and the Humber: 2%
- East Midlands: 2%
- West Midlands: 4%
- East of England: 11%
- London: 48%
- South East: 12%
- South West: 7%
- Wales: 1%
- Scotland: 2%
Who gets in
Based on about 25 students who started (a small group: a rough guide only)
- A levels: 90%
- Baccalaureate: 5%
- Other qualifications: 5%
Accreditation & quality ratings
TEF 2023 (whole university): Silver overall, Silver for student experience, Gold for student outcomes.
Modules
- Cancer Medicine in Society
- Foundations in Human Physiology and Cellular Biology
- Cardiovascular and Respiratory Function in Health and Disease
- The Gut, Liver and Drug Metabolism
- Kidneys, Hormones and Fluid Balance
- Infection, Inflammation and Repair
- Data Interpretation and Evaluation of Science
- Musculoskeletal Systems in Health and Disease
- Cancer Biology and Therapeutics
- Clinical Cancer: from epidemiology to diagnosis to treatment
- Pathogens and Cancer
- Radiation Cancer Biology
- Molecular Basis of Disease
- Techniques in Molecular Medicine: A Practical Approach
- Introduction to Clinical Trials
- Immunology
- The Nervous System and Neurological Diseases
- Pharmacology and Drug Action
- Introduction to Applied Genomics
- Nutrition and Cancer Risk
- Statistics for Medical Scientists
- Applied Tissue Engineering
- Paediatric and Young Adult Cancer: Basic Research and Clinical Applications
- Nutrition and Cancer Treatments
- Precision Cancer Medicine
- Cancer Clinical Trials - Undergraduate
- Structured Cancer Biomedicine Research Project
- The Biomedical Entrepreneur
- The Human Microbiome in Health and Disease
- Materials in Medicine
- Stem Cell Therapies
- Nanotechnology in Medicine
- Genetic Therapies and their Application in Medicine
- Cancer Literature Review
- Core Methods and Skills in Cancer Research
- Advanced Therapies in Cancer Care
- Extended Cancer Biomedicine Research Project
Questions about this course
How much do graduates of MSci Cancer Biomedicine at University College London earn?
The median salary is £40,000 after 15 months, £48,000 after 3 years, £52,000 after 5 years. After five years the middle half of graduates earn between £45,500 and £60,500.
What do graduates of MSci Cancer Biomedicine at University College London do next?
100% were in work or further study 15 months after finishing (Graduate Outcomes 2023-24).
Are students happy with the teaching on MSci Cancer Biomedicine at University College London?
92% of final-year students were positive about the teaching in the National Student Survey 2025-26.
What grades do I need for MSci Cancer Biomedicine at University College London?
The typical offer is AAA at A level, or 38 points in the IB. The average entrant had 151 UCAS points.
How many students continue on MSci Cancer Biomedicine at University College London?
82% of students continued into their second year, and 6% left higher education.